Chemoinformaics analysis of Demethylzeylasterone
| Molecular Weight | 496.6 | nRot | 2 |
| Heavy Atom Molecular Weight | 460.312 | nRig | 29 |
| Exact Molecular Weight | 496.246 | nRing | 5 |
| Solubility: LogS | -3.419 | nHRing | 0 |
| Solubility: LogP | 4.539 | No. of Aliphatic Rings | 4 |
| Acid Count | 2 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 72 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 1 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 78.0485 |
| nHD | 4 | BPOL | 38.7195 |
| QED | 0.388 |
| Synth | 4.782 |
| Natural Product Likeliness | 2.864 |
| NR-PPAR-gamma | 0.764 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.019 |
| Pgp-sub | 0.051 |
| HIA | 0.023 |
| CACO-2 | -5.996 |
| MDCK | 0.000008 |
| BBB | 0.086 |
| PPB | 0.983879 |
| VDSS | 0.364 |
| FU | 0.054241 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.929 |
| CYP2c19-inh | 0.011 |
| CYP2c19-sub | 0.077 |
| CYP2c9-inh | 0.098 |
| CYP2c9-sub | 0.045 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.053 |
| CYP3a4-inh | 0.1 |
| CYP3a4-sub | 0.122 |
| CL | 0.535 |
| T12 | 0.78 |
| hERG | 0.019 |
| Ames | 0.224 |
| ROA | 0.035 |
| SkinSen | 0.062 |
| Carcinogencity | 0.579 |
| EI | 0.038 |
| Respiratory | 0.929 |
| NR-Aromatase | 0.771 |
| Antiviral | Yes |
| Prediction | 0.83547 |